These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7751656)

  • 1. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG.
    Kozlowski PA; Black KP; Shen L; Jackson S
    J Immunol; 1995 Jun; 154(11):6163-73. PubMed ID: 7751656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
    Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
    J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
    Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
    J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.
    Lü FX
    Clin Immunol; 2000 Oct; 97(1):59-68. PubMed ID: 10998318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgA-mediated neutralization of HIV type 1.
    Burnett PR; VanCott TC; Polonis VR; Redfield RR; Birx DL
    J Immunol; 1994 May; 152(9):4642-8. PubMed ID: 8157978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals.
    Kozlowski PA; Chen D; Eldridge JH; Jackson S
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):813-22. PubMed ID: 7986587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.
    Marcelino JM; Nilsson C; Barroso H; Gomes P; Borrego P; Maltez F; Rosado L; Doroana M; Antunes F; Taveira N
    AIDS; 2008 Nov; 22(17):2257-65. PubMed ID: 18981765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA testing for diagnosis of retroviral infections in the Caribbean.
    Ridel PR; Artus JC; Capron A
    Bull Pan Am Health Organ; 1991; 25(3):201-6. PubMed ID: 1742565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients.
    Grossetête B; Viard JP; Lehuen A; Bach JF; Monteiro RC
    AIDS; 1995 Mar; 9(3):229-34. PubMed ID: 7755910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin profile in HIV-1 infected children in Dar es Salaam.
    Lyamuya EF; Matee MI; Kasubi M; Scheutz F
    East Afr Med J; 1999 Jul; 76(7):370-5. PubMed ID: 10520363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
    Williams SB; Flanigan TP; Cu-Uvin S; Mayer K; Williams P; Ettore CA; Artenstein AW; Duerr A; VanCott TC
    Clin Infect Dis; 2002 Sep; 35(5):611-7. PubMed ID: 12173138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of perinatally acquired HIV-1 infection using an IgA ELISA test.
    Liberatore D; Avila MM; Calarota S; Libonatti O; Martinez Peralta L
    Pediatr AIDS HIV Infect; 1996 Jun; 7(3):164-7. PubMed ID: 11361583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.
    Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG2 associated hypergammaglobulinaemia in some Nigerians with HIV infection.
    Uko GP; Griffiths M; Dawkins RL; Cobain T; Mohammed I; Hedo C; Okafor G; Umotong AB
    Afr J Med Med Sci; 1994 Dec; 23(4):385-9. PubMed ID: 7653407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of anti-Cryptosporidium IgA antibodies in sera from immunocompetent individuals and HIV-infected patients.
    Kassa M; Comby E; Lemeteil D; Brasseur P; Ballet JJ
    J Protozool; 1991; 38(6):179S-180S. PubMed ID: 1818157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
    Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of IgA anti-HIV antibodies in plasma from patients with HIV infection.
    Matsuda S; Noda M; Toyota A; Tokumoto S; Miyata M
    Microbiol Immunol; 1997; 41(10):785-90. PubMed ID: 9403502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.